全文获取类型
收费全文 | 1183篇 |
免费 | 62篇 |
国内免费 | 102篇 |
专业分类
耳鼻咽喉 | 18篇 |
儿科学 | 25篇 |
妇产科学 | 27篇 |
基础医学 | 205篇 |
口腔科学 | 18篇 |
临床医学 | 120篇 |
内科学 | 191篇 |
皮肤病学 | 9篇 |
神经病学 | 133篇 |
特种医学 | 9篇 |
外科学 | 170篇 |
综合类 | 117篇 |
预防医学 | 85篇 |
眼科学 | 30篇 |
药学 | 121篇 |
中国医学 | 28篇 |
肿瘤学 | 41篇 |
出版年
2023年 | 20篇 |
2022年 | 43篇 |
2021年 | 65篇 |
2020年 | 54篇 |
2019年 | 39篇 |
2018年 | 66篇 |
2017年 | 37篇 |
2016年 | 45篇 |
2015年 | 37篇 |
2014年 | 103篇 |
2013年 | 98篇 |
2012年 | 86篇 |
2011年 | 84篇 |
2010年 | 65篇 |
2009年 | 51篇 |
2008年 | 57篇 |
2007年 | 62篇 |
2006年 | 39篇 |
2005年 | 32篇 |
2004年 | 35篇 |
2003年 | 54篇 |
2002年 | 15篇 |
2001年 | 14篇 |
2000年 | 10篇 |
1999年 | 12篇 |
1998年 | 13篇 |
1997年 | 6篇 |
1996年 | 8篇 |
1995年 | 9篇 |
1994年 | 8篇 |
1993年 | 10篇 |
1992年 | 4篇 |
1991年 | 5篇 |
1990年 | 3篇 |
1989年 | 3篇 |
1988年 | 5篇 |
1987年 | 4篇 |
1986年 | 4篇 |
1985年 | 9篇 |
1984年 | 4篇 |
1982年 | 3篇 |
1980年 | 5篇 |
1979年 | 4篇 |
1977年 | 2篇 |
1976年 | 2篇 |
1974年 | 1篇 |
1973年 | 4篇 |
1972年 | 1篇 |
1971年 | 2篇 |
1965年 | 1篇 |
排序方式: 共有1347条查询结果,搜索用时 31 毫秒
1.
2.
3.
《Pancreatology》2022,22(2):175-184
BackgroundThe timing of oral refeeding can affect length of stay (LOS) and recovery of acute pancreatitis (AP). However, the optimal timing for oral refeeding is still controversial for AP. This meta-analysis investigated the effects of immediate or early versus delayed oral feeding on mild and moderate AP, regardless of improvement in clinical signs or laboratory indicators.MethodsThis systematic review and meta-analysis of randomized controlled trials (RCTs) based on data from Embase, Cochrane Library, PubMed, Web of science, and CBM before August 2021. Two researchers independently used Stata16 to extract and analyse study data. Random effect model was performed for meta-analysis to calculate the risk ratio (RR) and standardized mean difference (SMD).Results8 RCTs were selected, including 748 patients with mild to moderate AP. Patients in IOR (Immediate or early Oral Refeeding) group had less costs [SMD -0.83, 95%CI (?1.17, ?0.5), P < 0.001] and shorter LOS [SMD -1.01, 95%CI (?1.17, ?0.85), P < 0.001] than the DOR (Delayed Oral Refeeding) group patients. However, there was no difference in mortality [RR 0.54, 95%CI (0.11, 2.62), P = 0.44], pain relapse rate [RR 0.58, 95%CI (0.25, 1.35), P = 0.27], feeding intolerance rate [RR 0.61, 95%CI (0.28, 1.3), P = 0.2], AP progression rate [RR 0.21, 95%CI (0.04, 1.07), P = 0.06] and overall complications rate [RR 0.41, 95%CI (0.17, 1.01), P = 0.05] between the IOR and DOR groups.ConclusionsLimited data suggest that IOR could reduce LOS and costs without increasing adverse events in mild to moderate AP. 相似文献
4.
5.
6.
ObjectiveUlcerative colitis (UC) is one of the most common gastrointestinal diseases, characterized as a chronic, relapsing inflammation that causes damage to the colonic mucosa. Maresin 1 (MaR1), a specialized proresolving mediator, has powerful anti-inflammatory activity that prevents the occurrence of various inflammatory diseases. The aim of this study was to explore the role and potential mechanism of MaR1 in DSS-induced ulcerative colitis.MethodsIn the present study, we established dextran sulfate sodium (DSS)-induced ulcerative colitis rat model in vivo. Rats with colitis received tail vein injection of MaR1, with or without intraperitoneal injection of ML385. The changes of body weight, colon length, disease activity index (DAI), colonic histopathology, inflammatory cytokines, the activity of myeloperoxidase (MPO) and reactive oxygen species (ROS), and infiltration of macrophages expressing F4/80 were analyzed for the evaluation of colitis severity. In addition, protein expressions were detected using western blot.ResultsMaR1 significantly reduced inflammatory cytokines production, and restored body weight, DAI and colonic histopathology. Besides, MaR1 improved the expression of tight junction (TJ) proteins and reduced the infiltration of neutrophil and macrophages, as well as a decreased activity of MPO and ROS. Meanwhile, MaR1 activated Nrf2 signaling and decreased toll-like receptor 4(TLR4)/nuclear factor-κB(NF-κB) activation. Furthermore, ML385, an inhibitor of Nrf2, significantly reversed the protective effect of MaR1.ConclusionMaR1 play a protective role in DSS-induced colitis by activating Nrf2 signaling and inactivating Nrf2-mediated TLR4/NF-κB signaling pathway, which mediate proinflammatory mediators and intestinal TJ proteins in rats, providing novel insights into the therapeutic strategy of colitis. 相似文献
7.
8.
生物钟节律观与中医“天人一体”观相契合,生物钟节律紊乱可影响人体的生理病理状态,通过调节生物钟节律可达到提高治疗效果的目的。生物钟节律系统包括中枢生物钟节律系统与外周生物节律系统两大系统,分别在疾病发生发展中发挥不同的作用。与之相应,择时疗法是根据人体气血阴阳节律变化而选择相应药物治疗以达到最佳的疗效的一种时间医学治疗方法。临床上许多前列腺癌患者的发病与生物钟节律紊乱密切相关,通过调整生物钟节律具有预防和改善前列腺癌预后的积极作用。因此,本文将以现代生物钟节律的生理及病理机理为切入点,探讨不同生物钟节律系统紊乱在促前列腺癌中医主证形成过程中的发生机理,进而探讨择时治疗策略在不同类型前列腺癌治疗中运用的可行性,以期对前列腺癌的防治及预后产生一定的影响。 相似文献
9.
Xi Zhang Rui Gao Jin Ling Lin Ning Chen Qin Lin Gui Fang Huang Long Wang Xiao Huan Chen Fang Qin Xue Hong Li 《Journal of clinical nursing》2020,29(13-14):2196-2208
10.